Ocugen, Inc. (OCGN) Stock Losing Momentum in Aftermarket, Here’s the Reason.
Ocugen, Inc. (OCGN) is a late-stage biotherapeutics company engaged in the discovery, development, and commercialization of gene therapies to treat blindness-related diseases. The company is